Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 5
2012 4
2013 1
2014 3
2015 4
2016 3
2017 1
2018 1
2020 1
2021 4
2022 4
2023 3
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
Castilla J, García Cenoz M, Abad R, Sánchez-Cambronero L, Lorusso N, Izquierdo C, Cañellas Llabrés S, Roig J, Malvar A, González Carril F, Boone ALD, Pérez Martín J, Rodríguez Recio MJ, Galmés A, Caballero A, García Rojas A, Juanas F, Nieto M, Viloria Raymundo LJ, Martínez Ochoa E, Rivas AI, Castrillejo D, Moreno Pérez D, Martínez A, Borràs E, Sánchez Gómez A, Pastor E, Nartallo V, Arteagoitia JM, Álvarez-Fernández B, García Pina R, Fernández Arribas S, Vanrell J, García Hernández S, Mendoza RM, Méndez M, López-Tercero MM, Fernández-Rodríguez Á, Blanco Á, Carrillo de Albornoz FJ, Ruiz Olivares J, Ruiz-Montero R, Limia A, Navarro-Alonso JA, Vázquez JA, Barricarte A. Castilla J, et al. Among authors: castrillejo d. N Engl J Med. 2023 Feb 2;388(5):427-438. doi: 10.1056/NEJMoa2206433. N Engl J Med. 2023. PMID: 36724329
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.
Mazagatos C, Mendioroz J, Rumayor MB, Gallardo García V, Álvarez Río V, Cebollada Gracia AD, Batalla Rebollo N, Barranco Boada MI, Pérez-Martínez O, Lameiras Azevedo AS, López González-Coviella N, Castrillejo D, Fernández Ibáñez A, Giménez Duran J, Ramírez Córcoles C, Ramos Marín V, Larrauri A, Monge S; SARI Sentinel Surveillance RSV Study Group. Mazagatos C, et al. Among authors: castrillejo d. Influenza Other Respir Viruses. 2024 May;18(5):e13294. doi: 10.1111/irv.13294. Influenza Other Respir Viruses. 2024. PMID: 38716791 Free PMC article.
Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.
Vega-Piris L, Carretero SG, Mayordomo JL, Zarzuelo MBR, Río VÁ, García VG, Vázquez MG, Rodríguez MDCG, Basile L, González-Coviella NL, Boada MIB, Pérez-Martínez O, Azevedo AL, Rubio CQ, Duran JG, Ibáñez AF, Rivera MVG, Marín VR, Castrillejo D, Raymundo LJV, Larrauri A, Monge S; SARI Sentinel Surveillance Group. Vega-Piris L, et al. Among authors: castrillejo d. J Infect. 2024 Nov;89(5):106292. doi: 10.1016/j.jinf.2024.106292. Epub 2024 Sep 26. J Infect. 2024. PMID: 39341402 Free article.
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
Laniece Delaunay C, Mazagatos C, Martínez-Baz I, Túri G, Goerlitz L, Domegan L, Meijer A, Rodrigues AP, Sève N, Ilic M, Latorre-Margalef N, Lazar M, Maurel M, Melo A, Andreu Ivorra B, Casado I, Horváth JK, Buda S, Bennett C, de Lange M, Guiomar R, Enouf V, Mlinaric I, Samuelsson Hagey T, Dinu S, Rumayor M, Castilla J, Oroszi B, Dürrwald R, O'Donnell J, Hooiveld M, Gomez V, Falchi A, Kurecic Filipovic S, Dillner L, Popescu R, Bacci S, Kaczmarek M, Kissling E; VEBIS Primary Care Vaccine Effectiveness Group. Laniece Delaunay C, et al. JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258. JAMA Netw Open. 2024. PMID: 38949812 Free PMC article.
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022.
Suárez Rodríguez B, Guzmán Herrador BR, Díaz Franco A, Sánchez-Seco Fariñas MP, Del Amo Valero J, Aginagalde Llorente AH, de Agreda JPAP, Malonda RC, Castrillejo D, Chirlaque López MD, Chong Chong EJ, Balbuena SF, García VG, García-Cenoz M, Hernández LG, Montalbán EG, Carril FG, Cortijo TG, Bueno SJ, Sánchez AL, Linares Dópido JA, Lorusso N, Martins MM, Martínez Ochoa EM, Mateo AM, Peña JM, Antón AIN, Otero Barrós MT, Martinez MDCP, Jiménez PP, Martín OP, Rivas Pérez AI, García MS, Response Group NM, Soria FS, Sierra Moros MJ. Suárez Rodríguez B, et al. Among authors: castrillejo d. Emerg Infect Dis. 2022 Sep;28(9):1847-1851. doi: 10.3201/eid2809.221051. Epub 2022 Jul 12. Emerg Infect Dis. 2022. PMID: 35820165 Free PMC article.
Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.
Pérez-Gimeno G, Mazagatos C, Lorusso N, Basile L, Martínez-Pino I, Corpas Burgos F, Batalla Rebolla N, Rumayor Zarzuelo MB, Andreu Ivorra B, Giménez Duran J, Castrillejo D, Guiu Cañete I, Huerta Huerta M, García Becerril M, Ramos Marín V, Casas I, Pozo F, Monge S; SiVIRA group; Members of the SiVIRA sentinel surveillance study group. Pérez-Gimeno G, et al. Among authors: castrillejo d. Euro Surveill. 2024 Oct;29(40):2400618. doi: 10.2807/1560-7917.ES.2024.29.40.2400618. Euro Surveill. 2024. PMID: 39364601 Free PMC article.
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Kissling E, Pozo F, Martínez-Baz I, Buda S, Vilcu AM, Domegan L, Mazagatos C, Dijkstra F, Latorre-Margalef N, Kurečić Filipović S, Machado A, Lazar M, Casado I, Dürrwald R, van der Werf S, O'Donnell J, Linares Dopido JA, Meijer A, Riess M, Višekruna Vučina V, Rodrigues AP, Mihai ME, Castilla J, Goerlitz L, Falchi A, Connell J, Castrillejo D, Hooiveld M, Carnahan A, Ilić M, Guiomar R, Ivanciuc A, Maurel M, Omokanye A, Valenciano M; I-MOVE study team. Kissling E, et al. Among authors: castrillejo d. Influenza Other Respir Viruses. 2023 Jan;17(1):e13069. doi: 10.1111/irv.13069. Epub 2022 Nov 21. Influenza Other Respir Viruses. 2023. PMID: 36702797 Free PMC article.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Kissling E, Hooiveld M, Sandonis Martín V, Martínez-Baz I, William N, Vilcu AM, Mazagatos C, Domegan L, de Lusignan S, Meijer A, Machado A, Brytting M, Casado I, Murray JK, Belhillil S, Larrauri A, O'Donnell J, Tsang R, de Lange M, Rodrigues AP, Riess M, Castilla J, Hamilton M, Falchi A, Pozo F, Dunford L, Cogdale J, Jansen T, Guiomar R, Enkirch T, Burgui C, Sigerson D, Blanchon T, Martínez Ochoa EM, Connell J, Ellis J, van Gageldonk-Lafeber R, Kislaya I, Rose AM, Valenciano M; I-MOVE-COVID-19 primary care study team; I-MOVE-COVID-19 primary care study team (in addition to authors above). Kissling E, et al. Euro Surveill. 2021 Jul;26(29):2100670. doi: 10.2807/1560-7917.ES.2021.26.29.2100670. Euro Surveill. 2021. PMID: 34296676 Free PMC article.
36 results